← Leaderboards
Francesco Lotti
Columbia University Health Sciences
$2,369,210
Attributed
$2,369,210
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,369,210 · 3
By mechanism
R42$1,153,533 · 1
R01$775,677 · 1
R21$440,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Philip L De Jager$51,471,411
- George Z Mentis$12,085,277
- Ai Yamamoto$13,928,054
- Livio Pellizzoni$13,515,447
- Helen B Simpson$14,459,693
Others in their field
Other Emerging Leaders on “Molecular”
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Lynn Briscoe · Leidos Biomedical Research, Inc.$137,360,557
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$109,548,439
- Leonard Freedmand · Leidos Biomedical Research, Inc.$85,594,314
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
- Scott Hensley · University Of Pennsylvania$41,662,743
Research focus
MolecularAffectMessenger RnaMouse ModelNervous System DisorderGenesRna SplicingProteinsMutationSiteTranscriptPathologyBehavioralGene ExpressionInnovationNeurodegenerative DisordersEventNeuron LossNeuronsCellsMorphologyMediatingLinkMotor Neuron Function
Grant awards (7)
Developing RNA therapeutics for rare neurodevelopmental disorders$853,987
R42 · FY2025 · HD · contact PI
METTL3-mediated regulation of motor neuron function$353,963
R01 · FY2025 · AG · contact PI
METTL3-mediated regulation of motor neuron function$10,464
R01 · FY2024 · AG · contact PI
METTL3-mediated regulation of motor neuron function$411,250
R01 · FY2023 · AG · contact PI
Developing RNA therapeutics for rare neurodevelopmental disorders$299,546
R42 · FY2023 · HD · contact PI
SMN post-translational modification in Spinal Muscular Atrophy$200,000
R21 · FY2018 · NS · contact PI
SMN post-translational modification in Spinal Muscular Atrophy$240,000
R21 · FY2017 · NS · contact PI